Loading…
Scienture Holdings, Inc. is projected to rise to $0.3349 by 2027, a +1% move from its current price of $0.333. SCNX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.3221 | $0.3333 | $0.3449 | +0.09% |
| Jul 14 | $0.3178 | $0.3336 | $0.3501 | +0.17% |
| Jul 15 | $0.3146 | $0.3339 | $0.3543 | +0.26% |
| Jul 16 | $0.312 | $0.3341 | $0.3578 | +0.34% |
| Jul 17 | $0.3098 | $0.3344 | $0.3611 | +0.43% |
| Jul 18 | $0.3078 | $0.3347 | $0.364 | +0.51% |
| Jul 19 | $0.306 | $0.335 | $0.3668 | +0.60% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.306 | $0.335 | $0.3668 | +0.60% |
| Week 2 | $0.2965 | $0.337 | $0.3831 | +1.20% |
| Week 3 | $0.2898 | $0.339 | $0.3967 | +1.81% |
| Week 4 | $0.2845 | $0.3411 | $0.4089 | +2.42% |
| Week 5 | $0.2802 | $0.3431 | $0.4202 | +3.04% |
| Week 6 | $0.2765 | $0.3452 | $0.431 | +3.66% |
| Week 7 | $0.2732 | $0.3473 | $0.4414 | +4.28% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Scienture Holdings, Inc. operates as a pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen.
Scienture Holdings, Inc. is headquartered in Commack, New York.
SCNX is the listed ticker for Scienture Holdings, Inc. The stock currently trades at $0.3314, with a market capitalization of $13.47M and a rank of 5036. This places the asset among small-cap healthcare equities with ongoing CNS and cardiovascular drug development.
The current price is below key moving averages, which provides context for the near-term outlook.
A major floor 27.6% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.6% away) — a key level to hold.
The nearest ceiling, 25.8% above — a clean break opens room to run.
A major ceiling 53.5% above — clearing it would confirm fresh momentum.
Key SCNX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SCNX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.345 | Sell | $0.3498 | Sell |
| MA 10 | $0.3492 | Sell | $0.3518 | Sell |
| MA 20 | $0.3628 | Sell | $0.3595 | Sell |
| MA 50 | $0.3804 | Sell | $0.3758 | Sell |
| MA 100 | $0.3902 | Sell | $0.4243 | Sell |
| MA 200 | $0.5196 | Sell | $0.7413 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.37 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 33.22 | Neutral |
| Williams %R (14) | -23.53 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -3.14 | Sell |
| Bollinger %B (20,2) | 0.61 | Neutral |
| Stochastic %K (14) | 76.47 | Neutral |
| TRIX (15) | -0.37 | Sell |
| Awesome (5,34) | -0.03 | Sell |
| Ultimate (7,14,28) | 54.97 | Neutral |
| Momentum (10) | 0.00 | Buy |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 0.34 | Sell |
| ADX (14) | 14.93 | Neutral |
| ATR (14) | 0.01 | Info |
Technical sentiment is BEARISH. The RSI14 is 30, and the stock trades below the 50-day simple moving average of $0.3816 and the 200-day simple moving average of $0.5249. Support is at $0.331 and resistance at $0.419, framing a near-term path that could test the lower end of the range.
The 30-day price range spans from $0.2711 to $0.4051, and annualized volatility is 60%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.241 | $0.333 | $0.4866 | 0% | Neutral | |
| $0.2603 | $0.3349 | $0.4595 | +1% | Neutral | |
| $0.2488 | $0.3318 | $0.4761 | 0% | Neutral | |
| $0.246 | $0.3381 | $0.5023 | +2% | Neutral | |
| $0.2304 | $0.3252 | $0.4973 | -2% | Neutral | |
| $0.2655 | $0.3841 | $0.6024 | +15% | Neutral | |
| $0.2938 | $0.4348 | $0.6976 | +31% | Bullish | |
| $0.3007 | $0.4548 | $0.7448 | +37% | Bullish | |
| $0.3014 | $0.4654 | $0.7764 | +40% | Bullish | |
| $0.2748 | $0.4328 | $0.7347 | +30% | Bullish | |
| $0.3486 | $0.6017 | $1.10 | +81% | Bullish | |
| $0.4794 | $0.9742 | $1.97 | +193% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.241 | $0.333 | $0.4006 | +0.00% |
| August 2026 | $0.2952 | $0.3509 | $0.4302 | +5.39% |
| September 2026 | $0.3002 | $0.36 | $0.4474 | +2.58% |
| October 2026 | $0.2951 | $0.3565 | $0.4482 | -0.97% |
| November 2026 | $0.301 | $0.3661 | $0.4646 | +2.67% |
| December 2026 | $0.3106 | $0.3801 | $0.4866 | +3.82% |
Click any year to see its month-by-month SCNX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, SCNX could reach as high as $0.4866, with a base case around $0.333 and support toward $0.241 — roughly 0% from $0.333. A consolidation phase looks the most probable path here.
Expect SCNX to range from $0.2603 to $0.4595 through 2027. The $0.3349 average target implies a +1% move from current prices. That is up +1% on the projected 2026 average. Price action looks broadly range-bound.
The SCNX price prediction for 2028 points to an average of $0.3318 (low $0.2488, high $0.4761) — a potential decline of 0% on today's $0.333. A consolidation phase looks the most probable path here.
In 2029, SCNX is projected to trade between $0.246 and $0.5023, averaging $0.3381 — a potential gain of +2% from today's $0.333. That is up +2% on the projected 2028 average. Price action looks broadly range-bound.
Scienture Holdings, Inc.'s 2030 outlook centres on $0.3252, within a $0.2304 to $0.4973 range. That is -4% versus the projected 2029 average. That marks a -2% change versus current levels. A consolidation phase looks the most probable path here.
By 2031, SCNX could reach as high as $0.6024, with a base case around $0.3841 and support toward $0.2655 — roughly +15% from $0.333. Price action looks broadly range-bound.
Expect SCNX to range from $0.2938 to $0.6976 through 2032. The $0.4348 average target implies a +31% move from current prices. That is up +13% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The SCNX price prediction for 2033 points to an average of $0.4548 (low $0.3007, high $0.7448) — a potential gain of +37% on today's $0.333. Momentum favours further upside here.
In 2034, SCNX is projected to trade between $0.3014 and $0.7764, averaging $0.4654 — a potential gain of +40% from today's $0.333. That is up +2% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Scienture Holdings, Inc.'s 2035 outlook centres on $0.4328, within a $0.2748 to $0.7347 range. That is -7% versus the projected 2034 average. That marks a +30% change versus current levels. Momentum favours further upside here.
By 2040, SCNX could reach as high as $1.10, with a base case around $0.6017 and support toward $0.3486 — roughly +81% from $0.333. Buyers look set to stay in control over this stretch.
Expect SCNX to range from $0.4794 to $1.97 through 2050. The $0.9742 average target implies a +193% move from current prices. That is up +62% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in SCNX today (≈ 3,003.003003 SCNX) could be worth
$2,925.46
+$1,925.46 (+193%) by 2050 · US Dollar
Based on the average projected SCNX price of $0.97 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SCNXwould be worth at today's price.
$1,000 invested in SCNX on Jul 10, 2025 (≈ 609.756103 SCNX) would be worth
$203.05
-$796.95 (-79.7%) today · 0.20× · US Dollar
Based on a SCNX entry price of $1.64 vs. today's $0.333.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.344 | $968.02 | -3.2% |
| 1 month ago | $0.353 | $943.34 | -5.7% |
| 3 months ago | $0.333 | $1,000 | -0.0% |
| 6 months ago | $0.54 | $616.67 | -38.3% |
| 1 year ago | $1.64 | $203.05 | -79.7% |
| All time (5.0y) ago | $82.05 | $4.06 | -99.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SCNX forecast.
Our base-case forecast reaches $0.67 around 2050.
Implied market cap at $0.67: $27.22M
Forecasts show a shifting trajectory over the multi-year horizon. The 2026 average price is $0.3314 with a min of $0.241 and a max of $0.475, and a neutral sentiment. In 2027 the average is $0.3331 with a max of $0.4494 and a min of $0.2623, still neutral.
Through 2028 the range remains broadly flat ($0.3306 average) with a min of $0.2522 and a max of $0.4644, neutral sentiment. The forecast turns modestly positive in 2029 (average $0.3341, max $0.4844, min $0.2483, ROI 0.8, neutral). The 2030 outlook shows an average of $0.3167, a min of $0.2299, and a max of $0.4714 with ROI -4.5 and neutral sentiment.
Beginning in 2032, the forecast turns bullish, with 2032 average $0.4078 and ROI 23.1; 2033 average $0.4293 and ROI 29.5; 2034 average $0.4415 and ROI 33.2; 2035 average $0.4137 and ROI 24.8 (all bullish). The long-horizon 2040 forecast is strong, with average $0.5619, min $0.3436, max $0.9839 and ROI 69.5 (bullish). By 2050, the average is $0.8923, min $0.4764, max $1.72, with ROI 169.3 and bullish sentiment.
Tap a question to reveal the answer.
2030: avg $0.3167, min $0.2299, max $0.4714; ROI -4.5; sentiment NEUTRAL.
Near term shows neutral sentiment through 2026–2031 with averages around $0.33 and modest moves. From 2032 onward the forecast turns bullish, with higher expected averages (e.g., $0.4078 in 2032 and $0.8923 by 2050) and positive ROI (rising to 69.5% by 2040 and 169.3% by 2050).
Yes. The forecast shows a max of $1.72 in 2050.
Current price is $0.3314 and market cap is $13.47M.
2040: avg $0.5619, min $0.3436, max $0.9839; ROI 69.5; sentiment BULLISH.
Scienture Holdings, Inc. Community Discussion
0Share your Scienture Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.